Molecular based therapy
Nano / micro heme analysis
Variety of new drugs (ARNI / Check point inhibitors)
Next phase wearable monitors
Lead-less implantables
Population analytics incorporating geo mapping
Rapidly evolving prosthetics / exoskeletons
Healthcare (providers, hospitals, integrated systems, even the life science industry) will continue to be challenged by the changes associated with healthcare reform.
Meeting that challenge by focusing on 1) Quality; clinical outcomes, reducing unnecessary care, readmissions, safety, 2) Efficiency; care redesign / paths, coordination & access
as well as less costly venues for care delivery will be critical.
More to come.
